Neonatal Sepsis 

Neonatal sepsis may be categorized as early or late onset. Of newborns with early-onset infection, 85% present within 24 hours, 5% present at 24-48 hours, and a smaller percentage present within 48-72 hours. Onset is most rapid in premature neonates.

Early-onset sepsis syndrome is associated with acquisition of microorganisms from the mother. Transplacental infection or an ascending infection from the cervix may be caused by organisms that colonize in the mother's genitourinary tract, with acquisition of the microbe by passage through a colonized birth canal at delivery. The microorganisms most commonly associated with early-onset infection include the following^[1] :

• Group B Streptococcus (GBS)
• Escherichia coli
• Coagulase-negative Staphylococcus
• Haemophilus influenzae
• Listeria monocytogenes

Trends in the epidemiology of early-onset sepsis show a decreasing incidence of GBS sepsis. This can be attributed to the implementation of a prenatal screening and treatment protocol for GBS (see the image below).

In a 2009 study in 4696 women, prenatal cultures showed a GBS colonization rate of 24.5%, with a positive culture rate at the time of labor of 18.8%. Up to 10% of prenatally culture-negative women were found to be positive at the time of labor. With intrapartum antibiotic prophylaxis rates of 93.3%, 0.36 of 1000 infants developed early-onset GBS disease.^{[2, 3]}

Late-onset sepsis syndrome occurs at 4-90 days of life and is acquired from the caregiving environment. Organisms that have been implicated in causing late-onset sepsis syndrome include the following:

• Coagulase-negative staphylococci
• Staphylococcus aureus
• E coli
• Klebsiella
• Pseudomonas
• Enterobacter
• Candida
• Group B Streptococcus
• Serratia
• Acinetobacter
• Anaerobes

Trends in late-onset sepsis show an increase in coagulase-negative streptococcal sepsis; most of these isolates are susceptible to first-generation cephalosporins.^[2] The infant's skin, respiratory tract, conjunctivae, GI tract, and umbilicus may become colonized from the environment, leading to the possibility of late-onset sepsis from invasive microorganisms. Vectors for such colonization may include vascular or urinary catheters, other indwelling lines, or contact with caregivers who have bacterial colonization.

Pneumonia is more common in early-onset sepsis, whereas meningitis and bacteremia are more common in late-onset sepsis. Premature and ill infants have an increased susceptibility to sepsis and subtle nonspecific initial presentations; therefore, they require much vigilance so that sepsis can be effectively identified and treated.

When neonatal sepsis is suspected, treatment should be initiated immediately because of the neonate's relative immunosuppression. Begin antibiotics as soon as diagnostic tests are performed (see Treatment).

For patient education information, see Sepsis (Blood Infection).

The infectious agents associated with neonatal sepsis have changed over the past 50 years. S aureus and E coli were the most common bacterial pathogens in neonates during the 1950s in the United States. Over the ensuing decades, group B Streptococcus replaced S aureus as the most common gram-positive organism that caused early-onset sepsis. During the 1990s, group B Streptococcus and E coli continued to be associated with neonatal infection; however, coagulase-negative Staphylococcus epidermidis is now more frequently observed. Additional organisms, such as L monocytogenes, Chlamydia pneumoniae, H influenzae, Enterobacter aerogenes, and species of Bacteroides and Clostridium have also been identified in neonatal sepsis.

Meningoencephalitis and neonatal sepsis syndrome can also be caused by infection with adenovirus, enterovirus, or coxsackievirus. Additionally, sexually transmitted diseases (eg, gonorrhea, syphilis, herpes simplex virus [HSV], cytomegalovirus [CMV], hepatitis, human immunodeficiency virus [HIV], rubella, toxoplasmosis, Trichomonas vaginalis,Candida species) have all been implicated in neonatal infection.

Bacterial organisms with increased antibiotic resistance have also emerged and have further complicated the management of neonatal sepsis.^[4] The colonization patterns in nurseries and personnel are reflected in the organisms currently associated with nosocomial infection. In neonatal intensive care units (NICUs), infants with lower birth weight and infants who are less mature have an increased susceptibility to these organisms.

S epidermidis, a coagulase-negative Staphylococcus, is increasingly seen as a cause of nosocomial or late-onset sepsis, especially in the premature infant, in whom it is considered the leading cause of late-onset infections. Its prevalence is likely related to several intrinsic properties of the organism that allow it to readily adhere to the plastic mediums found in intravascular catheters and intraventricular shunts.

The bacterial capsule polysaccharide adheres well to the plastic polymers of the catheters. Also, proteins found in the organism (AtlE and SSP-1) enhance attachment to the surface of the catheter. The adherence creates a capsule between microbe and catheter, preventing C3 deposition and phagocytosis.

Biofilms are formed on indwelling catheters by the aggregation of organisms that have multiplied with the protection provided by the adherence to the catheter. Slimes are produced at the site from the extracellular material formed by the organism, which provides a barrier to the host defense, as well as antibiotic action, making coagulase-negative staphylococcal septicemia more difficult to treat. The toxins formed by this organism have also been associated with necrotizing enterocolitis.

In addition to being a cause of neonatal sepsis, coagulase-negative Staphylococcus is ubiquitous as part of the normal skin flora. Consequently, it is a frequent contaminant of blood and cerebrospinal fluid cultures. When a culture grows this organism , the clinical setting, colony counts, and presence of polymorphonuclear neutrophils (PMNs) on Gram stain of the submitted specimen often help differentiate true infection and positive culture from a false-positive or contaminated specimen.

In addition to the specific microbial factors mentioned above, numerous host factors predispose the newborn infant to sepsis. These factors are especially prominent in the premature infant and involve all levels of host defense, including cellular immunity, humoral immunity, and barrier function.

Cellular immunity

PMNs are vital for effective killing of bacteria. However, neonatal PMNs are deficient in chemotaxis and killing capacity. Decreased adherence to the endothelial lining of blood vessels reduces their ability to marginate and leave the intravascular space to migrate into the tissues. Once in the tissues, they may fail to degranulate in response to chemotactic factors.

Also, neonatal PMNs are less deformable; therefore, they are less able to move through the extracellular matrix of tissues to reach the site of inflammation and infection. The limited ability of neonatal PMNs for phagocytosis and killing of bacteria is further impaired when the infant is clinically ill. Lastly, neutrophil reserves are easily depleted because of the diminished response of the bone marrow, especially in the premature infant.

Neonatal monocyte concentrations are at adult levels; however, macrophage chemotaxis is impaired and continues to exhibit decreased function into early childhood. The absolute numbers of macrophages are decreased in the lungs and are likely decreased in the liver and spleen, as well. The chemotactic and bactericidal activity and the antigen presentation by these cells are also not fully competent at birth. Cytokine production by macrophages is decreased, which may be associated with a corresponding decrease in T-cell production.

Although T cells are found in early gestation in fetal circulation and increase in number from birth to about age 6 months, these cells represent an immature population. These naive cells do not proliferate as readily as adult T cells when activated and do not effectively produce the cytokines that assist with B-cell stimulation and differentiation and granulocyte/monocyte proliferation.

A delay occurs in the formation of antigen-specific memory function following primary infection, and the cytotoxic function of neonatal T cells is 50-100% as effective as adult T cells. At birth, neonates are deficient in memory T cells. As the neonate is exposed to antigenic stimuli, the number of these memory T cells increases.

Natural killer (NK) cells are found in small numbers in the peripheral blood of neonates. These cells are also functionally immature in that they produce far lower levels of interferon-gamma upon primary stimulation than do adult NK cells. This combination of findings may contribute to the severity of HSV infections in the neonatal period.

Humoral immunity

The fetus has some preformed immunoglobulin present, primarily acquired through nonspecific placental transfer from the mother. Most of this transfer occurs in late gestation, such that lower levels are found with increasing prematurity. The neonate's ability to generate immunoglobulin in response to antigenic stimulation is intact; however, the magnitude of the response is initially decreased, rapidly rising with increasing postnatal age.

The neonate is also capable of synthesizing immunoglobulin M (IgM) in utero at 10 weeks' gestation; however, IgM levels are generally low at birth, unless the infant was exposed to an infectious agent during the pregnancy, thereby stimulating increased IgM production.

Immunoglobulin G (IgG) and immunoglobulin E (IgE) may be synthesized in utero. Most of the IgG is acquired from the mother during late gestation. The neonate may receive immunoglobulin A (IgA) from breastfeeding but does not secrete IgA until 2-5 weeks after birth. Response to bacterial polysaccharide antigen is diminished and remains so during the first 2 years of life.

Complement protein production can be detected as early as 6 weeks' gestation; however, the concentration of the various components of the complement system widely varies among individual neonates. Although some infants have had complement levels comparable to those in adults, deficiencies appear to be greater in the alternative pathway than in the classic pathway.

The terminal cytotoxic components of the complement cascade that leads to killing of organisms, especially gram-negative bacteria, are deficient. This deficiency is more marked in preterm infants. Mature complement activity is not reached until infants are aged 6-10 months. Neonatal sera have reduced opsonic efficiency against GBS, E coli, and S pneumoniae because of decreased levels of fibronectin, a serum protein that assists with neutrophil adherence and has opsonic properties.

Barrier function

The physical and chemical barriers to infection in the human body are present in the newborn but are functionally deficient. Skin and mucous membranes are broken down easily in the premature infant. Neonates who are ill and/or premature are additionally at risk because of the invasive procedures that breach their physical barriers to infection.

Because of the interdependence of the immune response, these individual deficiencies of the various components of immune activity in the neonate conspire to create a hazardous situation for the neonate exposed to infectious threats.

Cardiopulmonary response to sepsis

In overwhelming sepsis, an initial early phase characterized by pulmonary hypertension, decreased cardiac output, and hypoxemia may occur. These cardiopulmonary disturbances may be due to the activity of granulocyte-derived biochemical mediators, such as hydroxyl radicals and thromboxane B2, an arachidonic acid metabolite.

These biochemical agents have vasoconstrictive actions that result in pulmonary hypertension when released in pulmonary tissue. A toxin derived from the polysaccharide capsule of type III Streptococcus has also been shown to cause pulmonary hypertension.

Gastrointestinal involvement in sepsis

The intestinal tract can be colonized by organisms in utero or at delivery by swallowing infected amniotic fluid. The immunologic defenses of the intestinal tract are not mature, especially in the preterm infant. Lymphocytes proliferate in the intestines in response to mitogen stimulation; however, this proliferation is not fully effective in responding to a microorganism because antibody response and cytokine formation are immature until approximately 46 weeks.

Necrotizing enterocolitis has been associated with the presence of a number of species of bacteria in the immature intestine. Overgrowth of these organisms in the neonatal lumen is a component of the multifactorial pathophysiology of necrotizing enterocolitis.

Meningitis

Ventriculitis is the initiating event in meningitis, with inflammation of the ventricular surface. Exudative material usually appears at the choroid plexus and is external to the plexus. Then, ependymitis occurs with disruption of the ventricular lining and projections of glial tufts into the ventricular lumen. Glial bridges may develop by these tufts and cause obstruction, particularly at the aqueduct of Sylvius.

The lateral ventricles may become multiloculated, which is similar to forming abscesses. Multiloculated ventricles can isolate organisms in an area, making treatment more difficult.

Meningitis is likely to arise at the choroid plexus and extend via the ventricles through aqueducts into the subarachnoid space to affect the cerebral and cerebellar surfaces. The high glycogen content in the neonatal choroid plexus provides an excellent medium for the bacteria. When meningitis develops from ventriculitis, it complicates effective treatment because achieving adequate antibiotic levels in the cerebral ventricles is difficult. When present, ventricular obstruction causes additional problems.

Arachnoiditis

Arachnoiditis is the next phase and is the hallmark of meningitis. The arachnoid is infiltrated with inflammatory cells that produce an exudate that is thick over the base of the brain and more uniform over the rest of the brain. Early in the infection, the exudate is primarily PMNs, bacteria, and macrophages. Exudate is prominent around the blood vessels and extends into the brain parenchyma.

In the second and third weeks of infection, the proportion of PMNs decreases; the dominant cells are histiocytes, macrophages, and some lymphocytes and plasma cells. Exudate infiltration of cranial roots 3-8 occurs.

After this period, the exudate decreases. Thick strands of collagen form, and arachnoid fibrosis occurs, which is responsible for obstruction. Hydrocephalus results. Early-onset group B Streptococcus meningitis is characterized by much less arachnoiditis than late-onset GBS meningitis.

Vasculitis

Vasculitis extends the inflammation of the arachnoid and ventricles to the blood vessels surrounding the brain. Occlusion of the arteries rarely occurs; however, venous involvement is more severe. Phlebitis may be accompanied with thrombosis and complete occlusion. Multiple fibrin thrombi are especially associated with hemorrhagic infarction. This vascular involvement is apparent within the first days of meningitis and becomes more prominent during the second and third weeks.

Cerebral edema

Cerebral edema may occur during the acute state of meningitis. The edema may be severe enough to greatly diminish the ventricular lumen. The cause is unknown, but it is likely related to vasculitis and the increased permeability of blood vessels. It may also be related to cytotoxins of microbial origin. Herniation of edematous supratentorial structures does not generally occur in neonates because of the cranium's distensibility.

Infarction

This is a prominent and serious feature of neonatal meningitis. It occurs in 30% of infants who die. Lesions occur because of multiple venous occlusions, which are frequently hemorrhagic. The loci of infarcts are most often in the cerebral cortex and underlying white matter but may also be subependymal within the deep white matter. Neuronal loss occurs, especially in the cerebral cortex, and periventricular leukomalacia may subsequently appear in areas of neuronal cell death.

The microorganisms most commonly associated with early-onset neonatal sepsis include the following^[1] :

• Group B Streptococcus (GBS)
• Escherichia coli
• Coagulase-negative Staphylococcus
• Haemophilus influenzae
• Listeria monocytogenes

Risk factors implicated in neonatal sepsis reflect the stress and illness of the fetus at delivery, as well as the hazardous uterine environment surrounding the fetus before delivery. The most common risk factors associated with early-onset neonatal sepsis are as follows:

• Maternal GBS colonization (especially if untreated during labor)
• Premature rupture of membranes (PROM)
• Preterm rupture of membranes
• Prolonged rupture of membranes
• Prematurity
• Maternal urinary tract infection
• Chorioamnionitis

Other factors associated with, or predisposing to, early-onset neonatal sepsis include the following^[5] :

• Low Apgar score (< 6 at 1 or 5 min)
• Maternal fever greater than 38°C
• Maternal urinary tract infection
• Poor prenatal care
• Poor maternal nutrition
• Low socioeconomic status
• History of recurrent abortion
• Maternal substance abuse
• Low birth weight
• Difficult delivery
• Birth asphyxia
• Meconium staining
• Congenital anomalies

Organisms that have been implicated in causing late-onset sepsis syndrome include the following:

• Coagulase-negative staphylococci
• Staphylococcus aureus
• E coli
• Klebsiella
• Pseudomonas
• Enterobacter
• Candida
• GBS
• Serratia
• Acinetobacter
• Anaerobes

Late-onset sepsis is associated with the following risk factors^[6] :

• Prematurity
• Central venous catheterization (duration >10 d)
• Nasal cannula or continuous positive airway pressure (CPAP) use
• H2 receptor blocker or proton pump inhibitor use
• Gastrointestinal tract pathology

Meningitis

The principal pathogens in neonatal meningitis are group B Streptococcus (36% of cases), Escherichia coli (31%), and Listeria species (5-10%). Other organisms that may cause meningitis include the following:

• Streptococcus pneumoniae
• Staphylococcus aureus
• Staphylococcus epidermidis
• Haemophilus influenzae
• Pseudomonas species
• Klebsiella species
• Serratia species
• Enterobacter species
• Proteus species

The incidence of culture-proven sepsis in the United States is approximately 2 per 1000 live births. Of the 7-13% of neonates who are evaluated for neonatal sepsis, only 3-8% have culture-proven sepsis. This disparity arises from the cautious approach to management of neonatal sepsis.

The early signs of sepsis in the newborn are nonspecific; therefore, many newborns undergo diagnostic studies and the initiation of treatment before the presence of sepsis has been proven. Additionally, because the American Academy of Pediatrics (AAP),^[7] American Academy of Obstetrics and Gynecology (AAOG), and Centers for Disease Control and Prevention (CDC)^[8] all have recommended sepsis screening and/or treatment for various risk factors related to group B Streptococcus infections, many asymptomatic neonates now undergo evaluation.

Because the mortality rate of untreated sepsis can be as high as 50%, most clinicians believe that the hazard of untreated sepsis is too great to wait for confirmation based on positive culture results. Therefore, most clinicians initiate treatment while awaiting culture results.

The implementation of a prenatal screening and treatment protocol for GBS has resulted in a decreasing incidence of GBS sepsis. This has changed the epidemiology of early-onset sepsis (see the image below).

Race-, sex-, and age-related demographics

Black infants have an increased incidence of group B Streptococcus disease and late-onset sepsis. This is observed even after controlling for risk factors of low birth weight and decreased maternal age. In all races, the incidence of bacterial sepsis and meningitis, especially for gram-negative enteric bacilli, is higher in males than in females.

Premature infants have an increased incidence of sepsis. The incidence of sepsis is significantly higher in infants with very low birth weight (< 1000 g), at 26 per 1000 live births, than in infants with a birth weight of 1000-2000 g, at 8-9 per 1000 live births. The risk of death or meningitis from sepsis is higher in infants with low birth weight than in full-term neonates.

With early diagnosis and treatment, term infants are not likely to experience long-term health problems associated with neonatal sepsis; however, if early signs and/or risk factors are missed, the mortality rate increases. Residual neurologic damage occurs in 15-30% of neonates with septic meningitis.

The mortality rate in neonatal sepsis may be as high as 50% for infants who are not treated. Infection is a major cause of fatality during the first month of life, contributing to 13-15% of all neonatal deaths. Low birth weight and gram-negative infection are associated with adverse outcomes.^[9] Neonatal meningitis, a serious morbidity of neonatal sepsis, occurs in 2-4 cases per 10,000 live births and significantly contributes to the mortality rate in neonatal sepsis; it is responsible for 4% of all neonatal deaths.

In preterm infants who have had sepsis, impaired neurodevelopment is a concern.^[10] Proinflammatory molecules may negatively affect brain development in this patient population. In a large study of about 6000 premature infants who weighed less than 1000 g at birth, preterm infants with sepsis who did not have meningitis had higher rates of cognitive deficits, cerebral palsy, and other neurodevelopmental disabilities, compared with infants who did not have sepsis.^{[11, 12]}

[#Miscellaneous]Infants with meningitis may acquire hydrocephalus and/or periventricular leukomalacia. They may also have complications associated with the use of aminoglycosides, such as hearing loss and/or nephrotoxicity.